Perimeter Medical Imaging AI to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update
Live Call/Audio Webcast to Begin at 5:00 pm ET Today
TORONTO & DALLAS–(BUSINESS WIRE)–Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced it will host a conference call to discuss its financial results for the year ended December 31, 2021 today at 5 pm ET.
Fourth Quarter/Year-End 2021 Results Conference Call Details:
Date: |
Tuesday, May 3, 2022 |
|
|
|
|
Time: |
5:00 p.m. ET |
|
|
|
|
Live Call: |
1-877-704-4453 (Canada and the United States) |
|
|
1-201-389-0920 (International) |
|
|
|
|
Audio Webcast: |
||
|
|
|
Replay Only: |
1-844-512-2921 or 1-412-317-6671 |
|
|
|
|
Conference ID: |
13729526 |
Details on company presentations and webcasts can be found on the “Investors” section of Perimeter’s website at https://ir.perimetermed.com/. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, our FDA-cleared Perimeter S-Series OCT imaging system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated, investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” refers to the pink ribbons used during Breast Cancer Awareness Month.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts
Shushu Feng
Perimeter Medical Imaging AI, Inc.
Direct: 647-339-7465 (PINK)
Toll-free: 888-988-7465 (PINK)
investors@perimetermed.com